Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HELQ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RASL12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GATA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR622 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RBBP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929240 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TAF6L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFRP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCNN1D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF559-ZNF177 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FXYD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIMM8A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBLL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDFY4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF641 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on